Filing Details
- Accession Number:
- 0001209191-14-066798
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-05 18:48:15
- Reporting Period:
- 2014-11-03
- Filing Date:
- 2014-11-05
- Accepted Time:
- 2014-11-05 18:48:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1505512 | Regulus Therapeutics Inc. | RGLS | Pharmaceutical Preparations (2834) | 264738379 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | 2855 Gazelle Court Carlsbad CA 92010 | No | No | Yes | No | |
| 1073385 | Lynne B Parshall | 2855 Gazelle Court Carlsbad CA 92010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-11-03 | 1,279,411 | $15.94 | 5,516,305 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The Reporting Person sold shares to the underwriters in connection with a registered public offering pursuant to the Issuer's Registration Statement on Form S-3 (No. 333-194293).
- The shares are held directly by Isis Pharmaceuticals, Inc. ("Isis"). Ms. Parshall is an officer and director of Isis and therefore may be deemed to have voting or investment power over the shares beneficially owned by Isis. Ms. Parshall disclaims beneficial ownership over the shares beneficially owned by Isis, except to the extent of her proportionate pecuniary interest therein as a stockholder of Isis.
Billionaire Hedge Funds
